Почетна › Рак на бешиката › Мисури

Клинички испитувања за Рак на бешиката во Мисури

27 студии за Рак на бешиката бараат учесници на локации во Мисури.

Градови во Мисури

Официјален текст на студијата (англиски)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Washington University School of Medicine in St. Louis, St Louis

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
и уште 21

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери

Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Saint Francis Medical Center, Cape Girardeau
Parkland Health Center - Farmington, Farmington
University of Kansas Cancer Center - Briarcliff, Kansas City
и уште 8

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06770582

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

University of Missouri Health Care ( Site 0126), Columbia

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06833073

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Washington University, School of Medicine, St Louis

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06172478

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Saint Francis Medical Center, Cape Girardeau

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07061964

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Missouri Cancer Associates, Columbia

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07566156

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Saint Francis Medical Center, Cape Girardeau
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
Siteman Cancer Center at West County Hospital, Creve Coeur
и уште 11

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Siteman Cancer Center - St. Peters, City of Saint Peters
Siteman Cancer Center - West County, Creve Coeur
Siteman Cancer Center - North County, Florissant
и уште 4

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Oncology Hematology Associates, Springfield
Washington University School of Medicine, St Louis

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07218380

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Washington University School of Medicine, St Louis

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT06529822

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Washington University, St Louis

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 18.9.2026 · NCT05267626

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Specialty Clinical Research of St. Louis, St Louis

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT06567743

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

Washington University School of Medicine, St Louis

Се регрутираНабљудувачка студија

Возраст од 18 до 50 · Жени · Ажурирано 2.9.2026 · NCT06904365

The Vanguard Study: Testing a New Way to Screen for Cancer

Saint Luke's Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

Се регрутираДобредојдени се здрави волонтери

Возраст од 45 до 75 · Сите полови · Ажурирано 2.9.2026 · NCT06995898

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Renown Regional Medical Center, St Louis
Specialty Clinic Research of St. Louis, St Louis

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 24.8.2026 · NCT05951179

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Renown Regional Medical Center, St Louis

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 21.8.2026 · NCT07480356

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Washington University in St. Louis, St Louis

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 20.8.2026 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Central Care Cancer Center - Bolivar, Bolivar
Mercy Cancer Center - Cape Girardeau, Cape Girardeau
Saint Francis Medical Center, Cape Girardeau
и уште 19

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT07097142

IDOV-Immune for Advanced Solid Tumors

Washington University School of Medicine, St Louis

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT06910657

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph

Се регрутираФаза 2

Возраст 8 и постари · Сите полови · Ажурирано 27.7.2026 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Kansas City

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT07720284

Integrated Cancer Repository for Cancer Research

Saint Luke's Cancer Institute, East, Kansas City
Saint Luke's Cancer Institute, Kansas City
Saint Luke's Cancer Institute, Kansas City North, Kansas City
и уште 3

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери

Возраст од 19 до 110 · Сите полови · Ажурирано 29.6.2026 · NCT02012699

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Mercy Hospital - SPG, Springfield
Mercy Hospital - South, St Louis
Mercy Hospital -STL, St Louis

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT07327489

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Washington University, St Louis

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 23.4.2026 · NCT05982561

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Washington University, St Louis

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 18.2.2026 · NCT07030257

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Kansas City
Massive Bio SYNERGY-AI site, St Louis

Се регрутираНабљудувачка студија

Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.